drugset / Trial / NCT02266264

Hyperglycemia and Effects of Daily 100 mg Versus 200 mg of Hydrocortisone Therapy in Patients With Septic Shock

NCT02266264

Phase 4 Completed 80 enrolled Srinakharinwirot University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare hyperglycemia and other effects, include 28-day mortality and time to reversal of shock between 100 milligrams and 200 milligrams of hydrocortisone as initial dosage in patients with septic shock.

Timeline

Start
2014-10
Primary completion
2017-05
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 100 mg
Subject Hydrocortisone Other / unclassified 200 mg

Indications